Biotech

A 20-year-old Madison biotechnology company will close by Dec. 31. Emd Chemicals - formerly Novagen - 441 Charmany Drive, told its 70 employees Thursday their jobs will end and their work will be consolidated into the company's San Diego site, part of a major restructuring that...

Mithridion, a Madison biotechnology company that is developing drugs for Alzheimer's disease and other central nervous system disorders, has raised another $2.9 million in venture capital. The latest round, led by Venture Investors, will be used for the clinical development of Mithridion's lead drug candidate,...

FDA scientists have lobbed a bombshell into the debate over new leadership and reform at the agency after President-elect Obama takes office. According to a letter nine of them wrote to Obama's transition team, sweeping changes are necessary at the agency to banish a corrupt,...

The Wisconsin Biotechnology & Medical Device Association, the member organization that represents the state's bioscience industry, has announced the election of six new members to its board of directors. The new board members include representatives from the Marshfield Clinic, Promega Corp., Flugen, Inc., Covance, GTI...

Doom and gloom in the topsy turvy biotechnology industry is nothing new, but biotech has endured tough times before, according to columnist Michael Rosen. In this year-end edition of Yer Biotech Blues, Rosen looks back at the often-jarring events and trends of 2008 and what...

A Madison biotechnology start-up that is developing an improved growth-factor supplement for stem cell researchers has received a $50,000 state grant, according to a report in the Milwaukee Journal Sentinel. Shiloh Laboratories, which was founded in 2007, has developed a growth supplement that is expected...

By Mark Johnson Using a simple skin biopsy from a young boy with a deadly genetic illness, scientists at the University of Wisconsin-Madison have provided the first demonstration that reprogramming can offer researchers an unprecedented view of human disease. The skin cells came from a boy with...

In his latest weekly address, President-elect Barack Obama said he has made appointments to his science and technology team based science and facts rather than ideology. The text of his address is as follows: “The truth is that promoting science isn't just about providing resources—it's about...